These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27656181)

  • 1. Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives.
    Jeffery HC; Braitch MK; Brown S; Oo YH
    Front Immunol; 2016; 7():334. PubMed ID: 27656181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease.
    Richardson N; Wootton GE; Bozward AG; Oo YH
    Semin Immunopathol; 2022 Jul; 44(4):461-474. PubMed ID: 35641679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease.
    Hann A; Oo YH; Perera MTPR
    Front Immunol; 2021; 12():719954. PubMed ID: 34721383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis.
    Oo YH; Ackrill S; Cole R; Jenkins L; Anderson P; Jeffery HC; Jones N; Jeffery LE; Lutz P; Wawman RE; Athwal AK; Thompson J; Gray J; Guo K; Barton D; Hirschfield GM; Wong T; Guest P; Adams DH
    JHEP Rep; 2019 Oct; 1(4):286-296. PubMed ID: 32039380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T Cell Metabolism in the Hepatic Microenvironment.
    Wawman RE; Bartlett H; Oo YH
    Front Immunol; 2017; 8():1889. PubMed ID: 29358934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation.
    Lam AJ; Hoeppli RE; Levings MK
    Transplantation; 2017 Oct; 101(10):2277-2287. PubMed ID: 28376037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation.
    Bernaldo-de-Quirós E; Pion M; Martínez-Bonet M; Correa-Rocha R
    Front Pediatr; 2022; 10():862807. PubMed ID: 35633970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.
    Esensten JH; Muller YD; Bluestone JA; Tang Q
    J Allergy Clin Immunol; 2018 Dec; 142(6):1710-1718. PubMed ID: 30367909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
    Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREG-cell therapies for autoimmune rheumatic diseases.
    Miyara M; Ito Y; Sakaguchi S
    Nat Rev Rheumatol; 2014 Sep; 10(9):543-51. PubMed ID: 24980140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose interleukin-2 promotes STAT-5 phosphorylation, T
    Jeffery HC; Jeffery LE; Lutz P; Corrigan M; Webb GJ; Hirschfield GM; Adams DH; Oo YH
    Clin Exp Immunol; 2017 Jun; 188(3):394-411. PubMed ID: 28176332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
    Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
    Front Immunol; 2019; 10():43. PubMed ID: 30804926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of changes in the Th17/Treg ratio in autoimmune liver disease.
    Feng TT; Zou T; Wang X; Zhao WF; Qin AL
    World J Gastroenterol; 2017 Jun; 23(21):3832-3838. PubMed ID: 28638223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.
    Ligocki AJ; Niederkorn JY
    Transplantation; 2015 Aug; 99(8):1553-9. PubMed ID: 26193065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    An Haack I; Derkow K; Riehn M; Rentinck MN; Kühl AA; Lehnardt S; Schott E
    PLoS One; 2015; 10(11):e0143715. PubMed ID: 26599014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
    Huang H; Deng Z
    Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
    Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: From occurrence to end stage of disease.
    Zhang H; Jiang Z; Zhang L
    Int Immunopharmacol; 2019 Apr; 69():50-59. PubMed ID: 30669025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.